Clinical trial
An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge…
NCT00307619 · Janssen-Cilag Farmaceutica Ltda., Industry · Completed
Key facts
| NCT number | NCT00307619 |
|---|---|
| Title | An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder. |
| Official title | Randomized, Double-blind Placebo Controlled Trial With Topiramate for the Treatment of Obese Patients With Binge Eating Disorder |
| Lead sponsor | Janssen-Cilag Farmaceutica Ltda., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Binge Eating |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 73 |
| Start date | Nov 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Mar 28, 2006 |
| Last update posted | Jan 31, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: